111 related articles for article (PubMed ID: 73116)
1. [Evolution of thyroximemia in the course of Basedow's disease treated with thyroid antagonists].
Linquette M; Fossati P; Decoulx M; Racadot A; Benoit G; Asfour M
Lille Med; 1977 Oct; 22(8):489-94. PubMed ID: 73116
[No Abstract] [Full Text] [Related]
2. [Proceedings: Effect of inorganic iodine on serum thyroxine concentration in Basedow's disease--in patients during treatment with antithyroid agents].
Ikeda H; Imai Y; Uchimura H; Matsuzaki F; Nagataki S
Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):408. PubMed ID: 4141670
[No Abstract] [Full Text] [Related]
3. [Basedow's disease in the pregnant woman. Should thyroxine be added to synthetic antithyroid drugs?].
Lutz P
Nouv Presse Med; 1976 Oct; 5(32):2081. PubMed ID: 62341
[No Abstract] [Full Text] [Related]
4. [Action of antithyroid drugs on the thyroid gland blood vessels in Basedow's disease].
Yamasaki T
Yonago Acta Med; 1966 Jul; 10(2):69-73. PubMed ID: 4167195
[No Abstract] [Full Text] [Related]
5. [Proceedings: Recovery rate in Basedow's disease treated with thyroid antagonists: frequency of development of suppression 1 year after the initiation of the treatment].
Nagataki S; Uchimura H; Ikeda H; Matsuzaki F; Imai Y
Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):424. PubMed ID: 4141673
[No Abstract] [Full Text] [Related]
6. [Hyperthyreosis in Basedow's disease].
Välimäki MJ
Duodecim; 1998; 114(5):447-54. PubMed ID: 11466937
[No Abstract] [Full Text] [Related]
7. The evolution of the ophthalmopathy during antithyroid drug therapy and its relationship with serum thyroglobulin and antithyroglobulin antibody in patients with Basedow's disease.
Bromberg N; Werner RS; Sgarbi JA; Werner MC; Romaldini JH
Exp Clin Endocrinol; 1991 May; 97(2-3):354-7. PubMed ID: 1717300
[No Abstract] [Full Text] [Related]
8. [L.A.T.S. activity during hyperthyroidism. Apropos of 143 cases of Basedow's disease].
Letonturier P; Tourneur R; Sénécal P
Ann Med Interne (Paris); 1974 May; 125(5):463-7. PubMed ID: 4140703
[No Abstract] [Full Text] [Related]
9. [The pharmacological therapy of Basedow's disease].
Lazzarin M; Segattini L; Benati F
Recenti Prog Med; 1993 Oct; 84(10):698-708. PubMed ID: 7694335
[TBL] [Abstract][Full Text] [Related]
10. [Basedow's disease. 1. Drug therapy of hyperthyroidism].
Tourniaire J
Lyon Med; 1971; 18():Suppl:48-51. PubMed ID: 4105819
[No Abstract] [Full Text] [Related]
11. [Basedow's disease].
Kumahara Y
Naika; 1965 Aug; 16(2):332-4. PubMed ID: 4161079
[No Abstract] [Full Text] [Related]
12. [Dynamic thyroid hormone levels during the thyrostatic treatment of Basedow's disease].
Vŭrbanov V; Zakharieva B; Manolov D
Vutr Boles; 1988; 27(4):15-8. PubMed ID: 2463711
[TBL] [Abstract][Full Text] [Related]
13. [Concerning "How often does thyrostatically treated Basedow's disease recur?" by H. Schleusener et al., Schweiz. med. Wschr. 1990; 120: 769-771].
Kürzl R
Schweiz Med Wochenschr; 1990 Sep; 120(38):1406-7. PubMed ID: 1699271
[No Abstract] [Full Text] [Related]
14. [Basedow's disease. Individual therapy of is great significance].
Hörmann R
MMW Fortschr Med; 2005 Sep; 147(35-36):47. PubMed ID: 16180573
[No Abstract] [Full Text] [Related]
15. [Clinical trials with thyroxin antagonists in Basedow's disease].
DELTOUR G; BRICAIRE H
Ann Endocrinol (Paris); 1954; 15(2):130-5. PubMed ID: 13181022
[No Abstract] [Full Text] [Related]
16. [Effect of antithyroid treatment on the pituitary thyrotropin reserve in patients with Basedow's disease].
Gianrossi R; Murialdo G; Gallamini A; Rolandi E
Boll Soc Ital Biol Sper; 1976 Dec; 52(24):2082-7. PubMed ID: 71904
[No Abstract] [Full Text] [Related]
17. [Serum thyroxine and triiodothyronine levels after a single dose and after 2-month-long thiamazole treatment of Graves' disease with reference to drug's pharmacokinetics].
Syrenicz A
Ann Acad Med Stetin; 1990; 36():133-52. PubMed ID: 2099104
[TBL] [Abstract][Full Text] [Related]
18. [Combination of low doses of 131-iodine and synthetic antithyroid agents for prolonged treatment in Basedow's disease. Apropos of 165 cases].
Mitouze J; Jaffiol C; Baldet L; Ghachem M
Rev Fr Endocrinol Clin; 1972; 13(4):339-61. PubMed ID: 4122472
[No Abstract] [Full Text] [Related]
19. [Proceedings: Effect of the volume of iodine uptake on recurrence of Basedow's disease: in patients with suppression of iodine uptake due to actions of antithyroid agents].
Nagataki S; Uchimura H; Ikeda H; Matsuzaki F; Imai Y
Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):409. PubMed ID: 4141671
[No Abstract] [Full Text] [Related]
20. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.
Bojarska-Szmygin A; Janicki K; Pietura R; Janicka L
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):248-53. PubMed ID: 15314994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
